Surrogate endpoints in early prostate cancer research

about

Surrogate endpoints in early prostate cancer research

Item

http://www.wikidata.org/entity/Q57112339

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2018

@uk

name

Surrogate endpoints in early prostate cancer research

@en

Surrogate endpoints in early prostate cancer research

@nl

type

Item

label

Surrogate endpoints in early prostate cancer research

@en

Surrogate endpoints in early prostate cancer research

@nl

prefLabel

Surrogate endpoints in early prostate cancer research

@en

Surrogate endpoints in early prostate cancer research

@nl

P1476

Surrogate endpoints in early prostate cancer research

@en

P2093

Scott Williams

http://www.w3.org/2001/XMLSchema#string

P2860

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

Increased survival with enzalutamide in prostate cancer after chemotherapy

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

A comparison of the prognostic value of early PSA test-based variables following external beam radiotherapy, with or without preceding androgen deprivation: analysis of data from the TROG 96.01 randomized trial.

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

Enzalutamide in metastatic prostate cancer before chemotherapy.

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer

Evaluation of the Houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time bias.

P304

472-482

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/TAU.2018.05.10

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30050805

http://www.w3.org/2001/XMLSchema#string

P921

urology

reproductive medicine

P932

6043744

http://www.w3.org/2001/XMLSchema#string